Addition of radium-223 to abiraterone acetate and prednisone or prednisolone in patients with castration-resistant prostate cancer and bone metastases (ERA 223): a randomised, double-blind, placebo-controlled, phase 3 trial

JOURNAL ARTICLE published March 2019 in The Lancet Oncology

Authors: Matthew Smith | Chris Parker | Fred Saad | Kurt Miller | Bertrand Tombal | Quan Sing Ng | Martin Boegemann | Vsevolod Matveev | Josep Maria Piulats | Luis Eduardo Zucca | Oleg Karyakin | Go Kimura | Nobuaki Matsubara | William Carlos Nahas | Franco Nolè | Eli Rosenbaum | Axel Heidenreich | Yoshiyuki Kakehi | Amily Zhang | Heiko Krissel | Michael Teufel | Junwu Shen | Volker Wagner | Celestia Higano